[1] SAVERIA I,MUSTIKA S. An 18-year-old man with idiopathic non-cirrhotic portal hypertension[J]. Acta Med Indones,2019,51(2):165-168.
|
[2] NICOLETTI V,GIOIA S,LUCATELLI P,et al. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension:Description,prevalence and risk factors[J]. Dig Liver Dis,2016,48(9):1072-1077.
|
[3] ZHAO LH,JIA JD. Idiopathic non-cirrhosis portal hypertension[J]. Chin Hepatol,2019,24(3):219-221.(in Chinese)赵连晖,贾继东.特发性非肝硬化性门脉高压[J].肝脏,2019,24(3):219-221.
|
[4] European Association for the Study of the Liver. EASL clinical practice guidelines:Vascular diseases of the liver[J]. J Hepatol,2016,64(1):179-202.
|
[5] SIRAMOLPIWAT S,SEIJO S,MIQUEL R,et al. Idiopathic portal hypertension:Natural history and long-term outcome[J].Hepatology,2014,59(6):2276-2285.
|
[6] XU H,ZHANG F,ZHANG M,et al. Effect of propranolol on hemodynamics and its clinical significance in patients with portal hypertension[J]. J Clin Hepatol,2019,35(4):801-807.(in Chinese)徐慧,张峰,张明,等.普萘洛尔对肝硬化门静脉高压患者血流动力学的影响和疗效观察[J].临床肝胆病杂志,2019,35(4):801-807.
|
[7] SARIN SK,GUPTA N,JHA SK,et al. Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension[J].Gastroenterology,2010,139(4):1238-1245.
|